Childhood parapneumonic effusions: Biochemical and inflammatory markers

Chest

Volumn 128, Issue 3, 2005, Pages 1436-1441

  Utine, G Eda ^a   Ozcelik, Ugur ^a   Yalcin, Ebru ^a   Dogru, Deniz ^a   Kiper, Nural ^a   Aslan, Ayse ^a   Kanra, Guler ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Inflammation; Interleukin 8; Nitric oxide; Pediatric parapneumonic effusions; Tumor necrosis factor

Indexed keywords

BIOCHEMICAL MARKER; GLUCOSE; INTERLEUKIN 8; LACTATE DEHYDROGENASE; NITRITE; PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ACCURACY; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DISEASE MARKER; EVALUATION; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LUNG EMPHYSEMA; MALE; NEUTROPHIL; PH; PLEURA EFFUSION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

EID: 24944472130     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.3.1436     Document Type: Article

References (21)

1. Efrati O, Barak A. Pleural effusions in the pediatric population. Pediatr Rev 2002; 23:417-426
2. Light RW, Rodriguez RM. Management of parapneumonic effusions. Clin Chest Med 1998; 19:373-382
3. Owens MW, Grisham MB. Nitric oxide synthesis by rat pleural mesothelial cells: induction by cytokines and lipopolysaccharide. Am J Physiol 1993; 265:L110-L116
4. Nevin BJ, Broadley KJ. Nitric oxide in respiratory diseases. Pharmacol Ther 2002; 95:259-293
5. Milligan SA, Owens MW, Grisham MB. Augmentation of cytoldne-induced nitric oxide synthesis by hydrogen peroxide. Am J Physiol 1996; 271:L114-L120
6. Moldawer LL. Biology of proinflammatory cytokines and their antagonists. Crit Care Med 1994; 22:S3-S7
7. Goodman RB, Wood RG, Martin TR, et al. Cytokine-stimulated human mesothelial cells produce chemotactic activity for neutrophils including NAP-1/IL-8. J Immunol 1992; 148:457-465
8. Odeh M, Sabo E, Srugo I, et al. Tumour necrosis factor alpha in the diagnostic assessment of pleural effusion. Q J Med 2000; 93:819-824
9. Rochester CL, Elias JA. Cytokines and cytoldne networking in the pathogenesis of interstitial and fibrotic lung disorders. Semin Respir Med 1993; 14:389-416
10. Antony VB, Godbey SW, Kunkel SL, et al. Recruitment of inflammatory cells to the pleural space: chemotactic cytokines, IL-8 and MCP-1 in human pleural fluids. J Immunol 1993; 151:7216-7223
11. Xirouchald N, Tzanalds N, Bouros D, et al. Diagnostic value of IL-1, IL-6, and TNF in pleural effusions. Chest 2002; 121:815-820
12. Djupesland PG, Chatkin JM, Qian W, et al. Nitric oxide in the nasal airway: a new dimension in otorhinolaryngology. Am J Otolaryngol 2001; 22:19-32
13. Schweniker A, Vodovotz Y, Weller R, et al. Nitric oxide and wound repair: role of cytokines? Nitric Oxide 2002; 7:1-10
14. Bryant RE, Salmon CJ. Pleural effusion and empyema. In: Mandell GL, Dolin R, Bennett JE, eds. Principles and practice of infectious diseases. 5th ed. Philadelphia, PA: Churchill Livingstone, 2000; 743-750
15. Lewis KT, Bukstein DA. Parapneumonic empyema in children: diagnosis and management. Am Fam Physician 1992; 46:1443-1455
16. Joseph J, Badrinath P, Basran GS, et al. Is the pleural fluid transudate or exudate? A revisit of the diagnostic criteria. Thorax 2001; 56:867-870
17. Agostoni E, Zocchi L. Mechanical coupling and liquid exchanges in the pleural space. Clin Chest Med 1998; 19:241-260
18. Cheng D, Rodriguez RM, Rogers J, et al. Comparison of pleural fluid pH values obtained using blood gas machine, pH meter, and pH indicator strip. Chest 1998; 114:1368-1372
19. Owens MW, Grimes SR. Pleural mesothelial cell response to inflammation: tumor necrosis factor-induced mitogenesis and collagen synthesis. Am J Physiol 1993; 265:L382-L388
20. Porcel JM, Vives M, Esquerda A. Tumor necrosis factor-α in pleural fluid: a marker of complicated parapneumonic effusions. Chest 2004; 125:160-164
21. Odeh M, Sabo E, Oliven A, et al. Role of TNF-α in the differential diagnosis of parapneumonic effusion. Int J Infect Dis 1999; 4:38-41